These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23967745)
1. [Effects of PPAR-alpha activation on oleic acid-induced steatosis and expression of heme oxygenase-1 in HepG2 cells]. Zhao JJ; Zhao LF; Yang H; Zhang L Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):218-21. PubMed ID: 23967745 [TBL] [Abstract][Full Text] [Related]
2. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006 [TBL] [Abstract][Full Text] [Related]
3. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863 [TBL] [Abstract][Full Text] [Related]
4. [Expression of aquaporin 3 and aquaporin 9 is regulated by oleic acid through the PI3K/Akt and p38 MAPK signaling pathways]. Gu LY; Qiu LW; Chen XF; Lv L; Mei ZC Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):753-8. PubMed ID: 24331633 [TBL] [Abstract][Full Text] [Related]
5. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells. Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255 [TBL] [Abstract][Full Text] [Related]
6. Oleic acid-induced hepatic steatosis is coupled with downregulation of aquaporin 3 and upregulation of aquaporin 9 via activation of p38 signaling. Gu LY; Qiu LW; Chen XF; Lü L; Mei ZC Horm Metab Res; 2015 Apr; 47(4):259-64. PubMed ID: 25105540 [TBL] [Abstract][Full Text] [Related]
7. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats]. Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188 [TBL] [Abstract][Full Text] [Related]
8. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680 [TBL] [Abstract][Full Text] [Related]
10. Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. Wu HT; Chen W; Cheng KC; Ku PM; Yeh CH; Cheng JT J Nutr Biochem; 2012 Oct; 23(10):1264-70. PubMed ID: 22209682 [TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
12. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a hepatocyte steatosis model using Chang liver cells. Yan D; Dou QL; Wang Z; Wei YY Genet Mol Res; 2015 Nov; 14(4):15224-32. PubMed ID: 26634485 [TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model]. Zhang Q; Zhang ZX; Fang Q; Gao FY; Zhao QL; Yang Y; Su HM; Liu YK Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):196-200. PubMed ID: 22475139 [TBL] [Abstract][Full Text] [Related]
15. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells. Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602 [TBL] [Abstract][Full Text] [Related]
16. [Effect of polyene phosphatidyl choline on hepatocyte steatosis via PPARα/CPT-1A pathway]. Wang T; Chen DF Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):291-6. PubMed ID: 27470629 [TBL] [Abstract][Full Text] [Related]
17. [Establishment and optimization of hepatocyte steatosis model]. Gao JX; Li XJ; Zhang W; Li YS; Tang HB Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):922-926. PubMed ID: 30669785 [No Abstract] [Full Text] [Related]
18. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells]. Zhou YP; Wu R; Shen W; Yu HH; Yu SJ Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760 [No Abstract] [Full Text] [Related]
19. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679 [TBL] [Abstract][Full Text] [Related]
20. [Study of synergistic effect of free fatty acid and iron on the establishment of nonalcoholic fatty liver disease model]. Wu Y; Ye Q; Zheng Q; Zhang L; Zhao Y Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Oct; 48(10):904-8. PubMed ID: 25573131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]